science_technology_and_other_research_and_development · DOD-AMRAA
DoW Kidney Cancer, Concept Award
Defense Health Agency Contracting Activity - DHACA · HT942526KCRPCA
Total Program Funding
$840K
Expected Awards
7
Deadline
August 11, 2026
GRANTQUICK SUMMARYPlain-English Overview
DoD's Kidney Cancer Research Program Concept Award funds 7 small grants ($840K total, ~$120K each) for highly innovative, early-stage kidney cancer research ideas. These are SEED grants — testing a new concept without requiring preliminary data. If you have a creative idea about kidney cancer but no pilot data yet, this gives you the money to generate it.
Who Should Apply
Researchers with innovative kidney cancer ideas at the earliest conceptual stage. No preliminary data required. Any career stage, any institution type.
Who Should NOT Apply
Researchers with established kidney cancer programs and extensive data (use Idea Development Awards), anyone proposing clinical trials, or researchers whose ideas aren't novel.
Key Requirements (Plain English)
- •Must propose highly innovative kidney cancer research concept
- •No preliminary data required
- •7 awards totaling $840K (~$120K each)
- •Must be early-stage/conceptual
- •Unrestricted eligibility
- •No cost-sharing required
💡 GrantQuick Tip
At $120K, Concept Awards are for testing one specific idea — not running a full research program. Think: 'I have a hypothesis that X causes kidney cancer, and $120K buys me the experiment to test it.' Reviewers want innovation over track record. If you're a researcher in a related field (immunology, metabolism, genetics) with a novel angle on kidney cancer, this is your entry point. No preliminary data needed means the barrier to entry is low — but the idea must be genuinely new.
Competitiveness: Low-moderate — 7 awards requiring no preliminary data. Good for researchers new to kidney cancer with creative hypotheses.
What This Grant Funds
Summary: The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Concept Award supports highly innovative, untested, potentially groundbreaking concepts, theories, paradigms and/or basic kidney cancer research. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation in kidney cancer. Applications must describe how the new concept will be innovative and present a novel course of investigation in the field of kidney cancer.
Distinctive Features:
• Preliminary data are not allowed.
• This is a blinded funding mechanism. Applications to this funding opportunity will undergo a double-blinded peer review. Applications must not include any materials that may identify the Principal Investigator (PI), a collaborator, or the organization of the PI or collaborator.
• Due to the blinded nature of the review process, identifying or making references to the PI, collaborator(s), or their organization(s) in the proposal (Project Narrative, List of Abbreviations, Acronyms, Symbols, Statement of Work, Impact Statement and Innovation Statement) is prohibited and will result in administrative rejection of the application.
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Total Program Funding
- $840K
- Expected Number of Awards
- 7
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
help@eBRAP.orgReady to apply?
View the full NOFO and submit your application on Grants.gov